Hubei Goto Biopharm Co Ltd Class A 300966
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 19.47
- Day Range
- CNY 18.58–20.85
- 52-Week Range
- CNY 12.03–28.78
- Bid/Ask
- CNY 20.44 / CNY 20.45
- Market Cap
- CNY 2.37 Bil
- Volume/Avg
- 7.6 Mil / 4.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 73.73
- Price/Sales
- 3.96
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Hubei Common Pharmaceutical Co Ltd is engaged in the research and development, production and sales of steroidal hormone drug raw materials.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 631
- Website
- http://www.gotopharm.com
Comparables
Valuation
|
Metric
|
300966
|
603896
|
603566
|
|---|---|---|---|
Price/Earnings (Normalized) | 73.73 | 22.53 | 59.99 |
Price/Book Value | 2.45 | 2.45 | 2.67 |
Price/Sales | 3.96 | 6.74 | 6.23 |
Price/Cash Flow | 22.27 | 18.86 | 30.06 |
Price/Earnings
300966
603896
603566
Financial Strength
|
Metric
|
300966
|
603896
|
603566
|
|---|---|---|---|
Quick Ratio | 0.73 | 3.29 | 2.52 |
Current Ratio | 1.61 | 3.64 | 3.00 |
Interest Coverage | 1.78 | 12.27 | — |
Quick Ratio
300966
603896
603566
Profitability
|
Metric
|
300966
|
603896
|
603566
|
|---|---|---|---|
Return on Assets (Normalized) | 1.28% | 7.77% | 3.63% |
Return on Equity (Normalized) | 3.05% | 11.42% | 4.33% |
Return on Invested Capital (Normalized) | 2.03% | 7.56% | 4.16% |
Return on Assets
300966
603896
603566
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Cmzdtvxw | Zzkp | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zqtnrswsg | Jhxfw | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Mgqyxryjj | Bystvl | $107.6 Bil | |
MRNA
| Moderna Inc | Wjykvtc | Byhy | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Pqltqtrp | Jxx | $22.2 Bil | |
ARGX
| argenx SE ADR | Pzdcfjwm | Kqdf | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Czddkkz | Qkqjvzg | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Hrctnhvs | Xkmplb | $15.1 Bil | |
INCY
| Incyte Corp | Rpbqntnxn | Rfwbnr | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Psnklxqbs | Fwzyrw | $12.7 Bil |